Not all sufferers with CLL have to have therapy. In spite of all current improvements, the iwCLL nonetheless suggests watchful observation for people with asymptomatic disease.86 This suggestion is based on not less than two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (F